MarketInOut Stock Screener Log In | Sign Up
 

Amphastar Pharmaceuticals Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 05/08/2026
Amphastar Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization835.48 mln
Float33.90 mln
Earnings Date05/08/2026

EPS

2.03
Solid

P / E

9.36
Undervalued

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.58
Likely reliable

1-Year Forecast

26.86
Exceptional upside

Relative Strength

9 / 100
Severely lagging

Business Description

Amphastar Pharmaceuticals is a drug maker based in Rancho Cucamonga, California, operating across the United States, China, and France since 1996. The company produces and sells a broad range of injectable, inhaled, and nasal medicines, covering both branded and generic treatments for conditions such as severe low blood sugar, asthma, opioid overdose, blood clots, and osteoporosis, among others. Amphastar also supplies raw pharmaceutical ingredients, including insulin, to support broader drug manufacturing needs.

Key Fundamentals

EPS2.03
P/E9.36
ROE12.88
RPS14.95
ROIC9.29
ROA6.04
Interest Cover5.51
EBITDA, mln212
EV / EBITDA7.06
EV / EBIT10.05
Revenue, mln720
EV / Revenue2.08

Financial Strength

Altman Z-Score2.36
Piotroski F-Score 6 / 9
Beneish M-Score-2.58
Price to Intrinsic Value0.43
Price to Lynch Fair Value0.30
Price to Graham Number1.13
1-Year Target Price26.86
Shiller PE Ratio14.50
Short Ratio7.77
Short % of Float18.14

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -13.16% 5 / 100   
1 Month -8.96% 12 / 100   
2 Months -28.27% 12 / 100   
6 Months -24.93% 21 / 100   
1 Year -22.23% 20 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us